Vor Biopharma Inc. is a clinical-stage biopharmaceutical company focused on developing therapies for autoimmune diseases. Its lead product candidate, telitacicept, is a novel fusion protein targeting BLyS/BAFF and APRIL to reduce B cell-mediated autoimmune responses. In-licensed from RemeGen Co., Ltd., telitacicept is approved in China for SLE, RA, and gMG, with global Phase 3 trials underway for gMG and Sjögren's disease outside Greater China.
Q2 FY2026 — expected 2026-09-17
| Filed | Period | Accession | Source | Full Text |
|---|---|---|---|---|
| 2026-03-30 | 2025-12-31 | 0001193125-26-130451 | EDGAR | 84K words |
| 2025-03-20 | 2024-12-31 | 0000950170-25-042623 | EDGAR | 90K words |
| 2024-03-20 | 2023-12-31 | 0000950170-24-034146 | EDGAR | 88K words |
| 2023-03-23 | 2022-12-31 | 0000950170-23-009472 | EDGAR | — |
| 2022-03-14 | 2021-12-31 | 0000950170-22-003577 | EDGAR | — |
| 2021-03-25 | 2020-12-31 | 0001564590-21-015474 | EDGAR | — |
| Filed | Period | Accession | Source | Full Text |
|---|---|---|---|---|
| 2026-08-11 | 2026-06-30 | 0001193125-26-343607 | EDGAR | 55K words |
| 2025-11-13 | 2025-09-30 | 0001193125-25-280104 | EDGAR | 56K words |
| 2025-08-12 | 2025-06-30 | 0000950170-25-107276 | EDGAR | 70K words |
| 2025-05-14 | 2025-03-31 | 0000950170-25-071349 | EDGAR | 15K words |
| 2024-11-07 | 2024-09-30 | 0000950170-24-123245 | EDGAR | 17K words |
| 2024-08-08 | 2024-06-30 | 0000950170-24-093858 | EDGAR | 16K words |
| 2024-05-09 | 2024-03-31 | 0000950170-24-056846 | EDGAR | 14K words |
| 2023-11-07 | 2023-09-30 | 0000950170-23-060200 | EDGAR | 17K words |
| 2023-08-10 | 2023-06-30 | 0000950170-23-041272 | EDGAR | 16K words |
| 2023-05-11 | 2023-03-31 | 0000950170-23-021188 | EDGAR | — |
| 2022-11-10 | 2022-09-30 | 0000950170-22-024444 | EDGAR | — |
| 2022-08-11 | 2022-06-30 | 0000950170-22-016853 | EDGAR | — |
| Filed | Accession | Source | Full Text |
|---|---|---|---|
| 2026-03-27 | 0001193125-26-127609 | EDGAR | 18K words |
| 2026-01-12 | 0001193125-26-009961 | EDGAR | 2K words |
| 2026-01-02 | 0001193125-26-000905 | EDGAR | 4K words |
| 2025-12-18 | 0001193125-25-324768 | EDGAR | 1K words |
| 2025-12-09 | 0001193125-25-311957 | EDGAR | 1K words |
| 2025-11-12 | 0001193125-25-275862 | EDGAR | 22K words |
| 2025-11-03 | 0001193125-25-261723 | EDGAR | 1K words |
| 2025-10-28 | 0001193125-25-253636 | EDGAR | 4K words |
| 2025-09-17 | 0001193125-25-205553 | EDGAR | 1K words |
| 2025-09-02 | 0001193125-25-193600 | EDGAR | 4K words |
88 total filings indexed. 60 additional filings (S-1, DEF 14A, etc.) View all (JSON) · SEC EDGAR
| CIK | 0001817229 |
| Ticker | VOR |
| Exchange | Nasdaq |
| SIC | 2836: Biological Products, (No Diagnostic Substances) |
| Website | https://www.vorbio.com |
| Listed | 2021-02-05 |
This is a static snapshot. For live, structured JSON with cryptographic provenance chain:
MCP (recommended for AI): claude mcp add origin --transport http https://origin.rootz.global/mcp
Try it — paste this into your AI:
Works in ChatGPT, Claude, Gemini, or any AI. Free, structured, cryptographically signed — ~500 tokens vs 130,000 scraping an IR site.
claude mcp add origin --transport http https://origin.rootz.global/mcpGET https://origin.rootz.global/api/company/VOR (~200 tokens, structured JSON with cryptographic provenance)